RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.
Clinical trial NCT06468267 · UNKNOWN
Trial details
- NCT number
- NCT06468267
- Sponsor
- Xianmin Song, MD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-15
- Primary completion
- 2026-07-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.